Robuta

Novo Nordisk's Wegovy pill is the first and only oral GLP-1 for weight loss in adults.

Dec 23, 2025 - Ed Cara 2025-12-23 10:50:00 gizmodo.com Losing weight has officially become more convenient. The popular GLP-1 obesity treatment Wegovy is now

Dec 23, 2025 - A pill version of the popular GLP-1 weight-loss drug Wegovy has been green-lit for use in the U.S. Here’s what that means for health care

Dec 24, 2025 - For the millions of Americans navigating the booming landscape of weight loss medications, the weekly injection routine just got a potential alternative. The

Dec 22, 2025 - With FDA approval of Wegovy pill, new era of oral GLP-1 weight loss drugs begins

A key to the pill's success will be attracting cash-paying consumers who cannot obtain insurance coverage, a stark shift from the dominant business model.

Feb 19, 2026 - The new Wegovy is for people who never thought they would use a GLP-1 — whether they just had a baby or are going into menopause.

Dec 24, 2025 - The FDA approved the one-a-day Wegovy pill, the first oral GLP-1 medication for obesity in the U.S., Wegovy manufacturer Novo Nordisk said in a statement...

Jan 5, 2026 - Danish drugmaker Novo Nordisk is launching its once-daily Wegovy pill in the United States on Monday, offering 1.5 milligram and 4 mg doses at $149 per month...

Dec 23, 2025 - The US Food and Drug Administration (FDA) has given a nod to a pill version of Novo Nordisk’s blockbuster weight-loss drug Wegovy. The drug, which uses the...

Dec 23, 2025 - While injectable medications have dominated the weight loss space for years, most people aren’t exactly pumped to stick themselves with a needle, so pills...

Dec 23, 2025 - Wegovy becomes first pill of its kind to be approved, shifting weight-loss drugs beyond injections.

Dec 23, 2025 - Some tout a daily semaglutide pill as a game-changer for weight-loss treatment.

Jan 6, 2026 - The pill was approved by the U.S. Food and Drug Administration last month, a boon to Novo Nordisk as it looks to regain ground lost to U.S. rival Eli Lilly.

Dec 23, 2025 - Vance finds critical support for a 2028 presidential run at a conservative conference.

Dec 23, 2025 - A semaglutide pill, an alternative to injections like Wegovy and Ozempic, has been approved for use by a major drug administration, welcoming a new era of...

Wegovy is now available as a daily pill, but experts say strict dosing schedules and more intense side effects may not make it a better option than the...

Dec 22, 2025 - The oral version of the obesity therapy led to similar efficacy as the injectable weight loss treatment in a late-stage clinical trial.

A pill version of weight-loss drug Wegovy will be manufactured in the Triangle and could be available within weeks after the FDA approved it Monday.

Jan 6, 2026 - Novo Nordisk's Wegovy, the first oral GLP-1 weight-loss pill, is now in 70,000+ US pharmacies, costing $5 (£4) to $10 (£7) per day.

Dec 24, 2025 - Says Indian launch is subject to internal decisions and due approvals from international and national regulatory authorities

Dec 22, 2025 - The Food and Drug Administration approved a pill version of Wegovy, Novo Nordisk’s blockbuster weight loss drug.

Dec 30, 2025 - Novo Nordisk pricing decisions suggest it's focusing on patients buying directly, perhaps more so than patients using insurance for weight loss drugs.

Jan 9, 2026 - The new oral Wegovy, launched this week, contains semaglutide, the same active ingredient as injectable Wegovy and Ozempic

Jan 9, 2026 - Eligible customers with insurance can pay as little as $25 for a one-month supply of the drug, while cash-paying options start at $149 a month, Amazon said.

Dec 23, 2025 - CNBC’s Annika Kim Constantino reports on the FDA's approval of the first GLP-1 pill for obesity from Wegovy maker Novo Nordisk.

Feb 11, 2026 - Hims & Hers introduced a $49 per month compounded semaglutide pill in early February— then pulled it from the market two days later.

Dec 22, 2025 - The approval gives Novo Nordisk a leg up in the race to market a potent oral medication for shedding pounds as it looks to regain lost ground from rival Eli...

Dec 23, 2025 - The approval gives Novo Nordisk a head start over chief rival Eli Lilly, which is racing to launch its own obesity pill.

Jan 16, 2026 - The early data is a boost to the Danish drugmaker's hopes of winning back more market share from Eli Lilly in the obesity drug space.

Dec 18, 2025 - Eli Lilly also said it has filed for Food and Drug Administration approval of the daily GLP-1 pill, called orforglipron, for obesity.

Fox News senior medical analyst Dr. Marc Siegel joins ‘Mornings with Maria’ to break down the new FDA-approved weight loss pill, concerns over cost and...

Jan 16, 2026 - Does the new Wegovy pill work as well as Wegovy injections for weight loss? How else does it compare? Learn what the experts say.

Jan 5, 2026 - Novo Nordisk's Wegovy pill is the first and only oral GLP-1 for weight loss in adults.

Dec 23, 2025 - This new pill contains the same active ingredient as injectable Wegovy and Ozempic, semaglutide. It is the first GLP-1 pill approved for losing excess weight.

Jan 5, 2026 - CBS News - A pill form of weight-loss drug Wegovy, manufactured by Danish drugmaker Novo Nordisk, is now available in the U.S., giving Americans access to an...

Dec 24, 2025 - A new era for weight loss

Dec 23, 2025 - Some tout a daily semaglutide pill as a game-changer for weight-loss treatment.

Jan 5, 2026 - Novo Nordisk's Wegovy pill is the first and only oral GLP-1 for weight loss in adults.

Dec 23, 2025 - Good news for people who are terrified of needles but interested in taking a GLP-1: On Monday, the FDA approved a pill version of Wegovy, which will hit the...